Cargando…
Low-dose rituximab should be used for treating MS in resource-limited settings: Yes
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131395/ https://www.ncbi.nlm.nih.gov/pubmed/35437089 http://dx.doi.org/10.1177/13524585221089890 |
_version_ | 1784713165714489344 |
---|---|
author | Piehl, Fredrik Mathew, Thomas |
author_facet | Piehl, Fredrik Mathew, Thomas |
author_sort | Piehl, Fredrik |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9131395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-91313952022-05-26 Low-dose rituximab should be used for treating MS in resource-limited settings: Yes Piehl, Fredrik Mathew, Thomas Mult Scler Controversies in Multiple Sclerosis SAGE Publications 2022-04-18 2022-06 /pmc/articles/PMC9131395/ /pubmed/35437089 http://dx.doi.org/10.1177/13524585221089890 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Controversies in Multiple Sclerosis Piehl, Fredrik Mathew, Thomas Low-dose rituximab should be used for treating MS in resource-limited settings: Yes |
title | Low-dose rituximab should be used for treating MS in resource-limited
settings: Yes |
title_full | Low-dose rituximab should be used for treating MS in resource-limited
settings: Yes |
title_fullStr | Low-dose rituximab should be used for treating MS in resource-limited
settings: Yes |
title_full_unstemmed | Low-dose rituximab should be used for treating MS in resource-limited
settings: Yes |
title_short | Low-dose rituximab should be used for treating MS in resource-limited
settings: Yes |
title_sort | low-dose rituximab should be used for treating ms in resource-limited
settings: yes |
topic | Controversies in Multiple Sclerosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131395/ https://www.ncbi.nlm.nih.gov/pubmed/35437089 http://dx.doi.org/10.1177/13524585221089890 |
work_keys_str_mv | AT piehlfredrik lowdoserituximabshouldbeusedfortreatingmsinresourcelimitedsettingsyes AT mathewthomas lowdoserituximabshouldbeusedfortreatingmsinresourcelimitedsettingsyes |